Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111094557B details novel ADH mutants enabling cost-effective, high-ee biocatalytic synthesis of chiral biaryl alcohols for antihistamine drugs.
Patent CN112941114A reveals high-purity enzymatic route for chiral triols. Reduces production cost and improves supply chain reliability for global pharmaceutical intermediates manufacturing.
Patent CN114381441B reveals imine reductase catalysis for optical pure chiral amino alcohols. Offers mild conditions and high stereoselectivity for pharmaceutical supply chains.
Patent CN115948356B reveals high-efficiency carbonyl reductase mutants for lipoic acid intermediates, offering supply chain stability and cost reduction.
Novel enzymatic synthesis route for HIV integrase inhibitor intermediates. High purity, scalable process offering significant supply chain stability and cost efficiency for pharmaceutical partners.
Patent CN117821355A reveals efficient enzymatic synthesis for ferulic acid. Discover cost reduction and supply chain advantages for pharmaceutical intermediates manufacturing.
Patent CN104388490A reveals high-yield biocatalytic route. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel enzymatic synthesis method for high-purity chiral cis-cyclohexanediamine. Scalable process reduces impurities and ensures supply chain reliability for anticoagulant manufacturing.
Patent CN105755095B details enzymatic synthesis of chiral hydroxy acids. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN102260721A details a green enzymatic route for Levetiracetam intermediates, offering significant cost reduction in API manufacturing and superior supply chain reliability.
Patent CN1778889A details high-purity S-CHBE production via Aureobasidium pullulans. This method offers significant cost reduction and supply chain reliability for global buyers.
Patent CN104651243B details high-yield biocatalytic synthesis of (R)-1,3-butanediol. Offers superior purity and cost-effective supply chain solutions for antibiotic manufacturing.
Patent CN109762768B details a novel Bacillus B8W22 strain for producing high-purity pharmaceutical intermediates with superior stereoselectivity and reduced environmental impact.
Patent CN102978251A reveals a low-cost enzymatic route for L-tert-leucine. Achieve >99% optical purity and significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN104561136B enables high-yield chemo-enzymatic synthesis. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Novel L-threonine aldolase enables green synthesis of antibiotic intermediates with high stereoselectivity and reduced environmental impact.
Patent CN100385007C details a microbial method for (R)-mandelic acid using Brevibacterium flavum, offering high optical purity and scalable biocatalysis for pharma intermediates.
Patent CN109749968B reveals a novel Bacillus velezensis strain for synthesizing chiral intermediates. This breakthrough offers significant cost reduction in API manufacturing and superior supply chain reliability.
Patent CN101824438B details microbial synthesis of high-purity (S)-EHB using yeast. Offers cost-effective, scalable pharmaceutical intermediate solutions.
Patent CN114277023A details a novel biocatalytic route using recombinant E. coli and ion exchange resin for >99.99% purity nicotinamide.